Rathbones Group PLC Sells 6,068 Shares of STERIS plc (NYSE:STE)

Rathbones Group PLC reduced its position in STERIS plc (NYSE:STE - Free Report) by 4.9% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 117,928 shares of the medical equipment provider's stock after selling 6,068 shares during the period. Rathbones Group PLC owned about 0.12% of STERIS worth $24,241,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. Geode Capital Management LLC increased its stake in shares of STERIS by 2.4% during the 4th quarter. Geode Capital Management LLC now owns 2,359,748 shares of the medical equipment provider's stock worth $483,775,000 after purchasing an additional 56,123 shares during the last quarter. Mitsubishi UFJ Asset Management Co. Ltd. boosted its holdings in STERIS by 15.9% in the fourth quarter. Mitsubishi UFJ Asset Management Co. Ltd. now owns 1,261,927 shares of the medical equipment provider's stock worth $257,585,000 after purchasing an additional 172,795 shares in the last quarter. Franklin Resources Inc. increased its position in STERIS by 45.1% during the fourth quarter. Franklin Resources Inc. now owns 1,216,821 shares of the medical equipment provider's stock worth $250,130,000 after buying an additional 378,252 shares during the last quarter. Norges Bank bought a new position in STERIS during the fourth quarter valued at about $238,836,000. Finally, Pictet Asset Management Holding SA lifted its position in shares of STERIS by 3.1% in the fourth quarter. Pictet Asset Management Holding SA now owns 1,131,374 shares of the medical equipment provider's stock worth $232,565,000 after buying an additional 33,618 shares during the last quarter. Institutional investors own 94.69% of the company's stock.

Remove Ads

STERIS Stock Performance

Shares of STE stock traded up $4.06 during trading hours on Friday, reaching $221.18. 459,313 shares of the company's stock were exchanged, compared to its average volume of 535,127. STERIS plc has a fifty-two week low of $197.82 and a fifty-two week high of $248.24. The company has a quick ratio of 1.40, a current ratio of 2.13 and a debt-to-equity ratio of 0.32. The stock has a market capitalization of $21.73 billion, a P/E ratio of 46.96 and a beta of 0.87. The business has a fifty day moving average price of $222.61 and a 200-day moving average price of $219.50.

STERIS (NYSE:STE - Get Free Report) last announced its earnings results on Wednesday, February 5th. The medical equipment provider reported $2.32 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $2.33 by ($0.01). STERIS had a return on equity of 13.91% and a net margin of 8.66%. Analysts predict that STERIS plc will post 9.08 EPS for the current fiscal year.

STERIS Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Friday, March 21st. Investors of record on Thursday, February 20th were given a dividend of $0.57 per share. This represents a $2.28 dividend on an annualized basis and a yield of 1.03%. The ex-dividend date of this dividend was Thursday, February 20th. STERIS's dividend payout ratio (DPR) is presently 48.41%.

Analysts Set New Price Targets

A number of research analysts recently weighed in on the company. JMP Securities reissued a "market outperform" rating and issued a $265.00 price objective on shares of STERIS in a research note on Thursday. Stephens reissued an "overweight" rating and issued a $240.00 price target on shares of STERIS in a research report on Thursday, February 6th. Piper Sandler upped their price objective on shares of STERIS from $260.00 to $265.00 and gave the stock an "overweight" rating in a report on Monday, February 3rd. Finally, Needham & Company LLC reiterated a "hold" rating on shares of STERIS in a report on Monday, April 7th. One analyst has rated the stock with a hold rating and five have given a buy rating to the company's stock. Based on data from MarketBeat, STERIS has an average rating of "Moderate Buy" and a consensus price target of $258.75.

STERIS Company Profile

STERIS plc provides infection prevention products and services worldwide. It operates through four segments: Healthcare, Applied Sterilization Technologies, Life Sciences, and Dental. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; endoscopy accessories, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in the operating room, including surgical tables, lights, and connectivity solutions, as well as equipment management services.